ALNYLAM PHARMACEUTICALS, INC. (ALNY) Net income 2016–2025
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$313.7MFY2025 · since FY2016: -$410.1M → $313.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $313.7M | +212.8% |
| FY2024 | -$278.2M | +36.8% |
| FY2023 | -$440.2M | +61.1% |
| FY2022 | -$1.1B | -32.6% |
| FY2021 | -$852.8M | +0.6% |
| FY2020 | -$858.3M | +3.1% |
| FY2019 | -$886.1M | -16.4% |
| FY2018 | -$761.5M | -55.1% |
| FY2017 | -$490.9M | -19.7% |
| FY2016 | -$410.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice